Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty percent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis,...

Full description

Bibliographic Details
Main Authors: Henao-Mejia, Jorge, Elinav, Eran, Jin, Cheng-Cheng, Hao, Liming, Mehal, Wajahat Z., Strowig, Till, Thaiss, Christoph A., Kau, Andrew L., Eisenbarth, Stephanie C., Jurczak, Michael J., Camporez, Joao-Paulo, Shulman, Gerald I., Gordon, Jeffrey I., Hoffman, Hal M., Flavell, Richard A.
Format: Online
Language:English
Published: 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276682/